NYSE ARCA | ETF
The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective.
The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards (GICS).
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 2.15% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 1.86% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 1.80% |
| HALO | Halozyme Therapeutics Inc | Healthcare | Biotechnology | 1.78% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 1.62% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 1.60% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 1.55% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 1.54% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.53% |
| BBIO | BridgeBio Pharma Inc | Healthcare | Biotechnology | 1.50% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 1.49% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 1.45% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 1.44% |
| BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 1.44% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 1.41% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 1.40% |
| MDGL | Madrigal Pharmaceuticals Inc | Healthcare | Biotechnology | 1.35% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 1.32% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 1.29% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 1.24% |